2025 Partners
Lead Partner:
Serina Therapeutics
Serina is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases. Serina’s POZ PlatformTM technology is engineered to provide greater control and precision in drug loading and the rate of release of attached drugs, enabling the potential of challenging small molecules, while addressing the limitations of other biocompatible polymers. POZ PlatformTM partners are at the forefront in advancing lipid nanoparticle (LNP) delivery technology to develop novel RNA therapeutics..
Expertise Partner:
ReciBioPharm
ReciBioPharm is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize advanced therapy medicinal products (ATMPs).
ReciBioPharm’s specialized CDMO capabilities include pre-clinical to clinical and commercial development and manufacture for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production.
Headed by a management team and technical experts with a proven track record in both process development and contract manufacturing, ReciBioPharm offers the knowledge and resources necessary to help customers develop and manufacture promising new therapies to meet the needs of patients across the world.
Program Partners:
Corden Pharma
CordenPharma offers advanced LNP formulation technologies, back-integrated lipid synthesis, and forward-integrated sterile injectable manufacturing services to create a proven, truly integrated, commercialization pathway for your xRNA based therapeutics. Our LNP manufacturing strategies, based on ethanol injection, are tailored to encapsulate a broad variety of genetic payloads. We also offer LNP Starter Kits (which provide researchers the essential components needed to create and optimize their own LNPs for xRNA/xDNA delivery), key standard and proprietary lipids ideally suited for mRNA applications, and support sterile injectable PFS, vials, ampoules & lyophilized vials with a wide range of filling volumes.
MilliporeSigma
MilliporeSigma is the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany. We provide solutions to help you overcome your mRNA manufacturing and LNP formulation challenges. Our integrated CTDMO capabilities include the development and manufacturing of custom mRNAs, synthetic lipids, lipid nanoparticle (LNP) formulation and fill and finish. Discover how our capabilities, technical expertise and regulatory know-how can help you deliver and scale up your mRNA-based vaccines and therapeutics, accelerate time to market and mitigate risks.
www.SigmaAldrich.com/MilliporeCTDMOServices
FUJIFILM
FUJIFILM Corporation is transforming into a healthcare company through leveraging fine-chemical technologies cultivated in photo-films’ manufacturing, such as organic-chemistry and nanotechnologies. Based on these assets, we have started one-stop CDMO service from bench top formulation research to GMP manufacturing for lipid nanoparticles utilizing Fujifilm's proprietary ionizable lipids.
Lipoid
Since its foundation in 1977, Lipoid has gained an outstanding reputation in the development and industrial production of high-quality lecithin, phospholipids, and other lipid products, meeting the high standards of the pharmaceutical industry. Lipoid is the world’s leading company for the production and supply of a wide range of natural and synthetic phospholipid excipients on an industrial scale.
NOF
NOF CORPORATION is the leading commercial supplier of GMP grade activated PEGs, lipids and ultrapure Polysorbates 80 for drug delivery products through R&D to commercial scale. We provide a wide range of lipids (ionizable, PEG, and phospho) for lipid nanoparticle formulations (LNP). Our LNP platform, containing our ionizable lipid (COATSOME® SS Series), has excellent endosomal escape ability and provides high gene expression with low toxicity. It is capable of applying to gene delivery, gene editing, and RNA vaccine application under this platform.
MepsGen
MEPSGEN develops advanced microfluidic platforms designed for seamless scalability, from lab-scale processes to fully automated large-scale GMP manufacturing of lipid nanoparticles (LNPs). NanoCalibur™ is a scalable nanoparticle synthesis system equipped with high-precision feedback control for precursor flow rates, enabling the production of uniform LNPs encapsulating mRNA, antisense oligonucleotides (ASOs), and peptides with exceptional encapsulation efficiency, consistency, and scalability. Its automated, closed-loop pressure control system effectively manages unexpected disturbances during LNP production, offering a significant advantage over conventional nanoparticle synthesis technologies that rely on open-loop syringe pump-based configurations.
ThermoFisher
Thermo Fisher Scientific leads in serving science and is dedicated to making the world healthier,
cleaner, and safer. We accelerate innovation and productivity by offering advanced lipid nanoparticle (LNP) products and services for in vivo delivery of nucleic acid payloads. Our comprehensive
solutions include ionizable lipids, custom LNP compositions, and LNP formulation and
characterization services. Our Vivofectamine LNP portfolio provides a diverse library of ionizable
lipids and LNP formats, and flexible licensing terms to support the commercialization of nucleic acid therapeutics.
Quantum Si
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® Pro benchtop instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Detecting single amino acids through binding kinetics, the innovative Platinum® Pro benchtop sequencer is highly sensitive to protein variants, enabling deep interrogation of proteins to deliver breakthrough insights.
Beckman Coulter
With a relentless mission to empower those seeking answers to life’s important scientific questions, Beckman Coulter Life Sciences is a preferred laboratory partner providing automation and innovation solutions for Centrifugation, Flow Cytometry, Genomics, Particle Analysis, and Liquid Handling workflows. With a legacy dating back to 1935, our technologies reduce manual laboratory processes and can provide greater speed, accuracy, and advanced analytics to accelerate answers with a guiding focus to improve patient care and enable pioneering discoveries. Beckman Coulter Life Sciences is headquartered in Indianapolis, Indiana with 11 operational hubs around the world and employs more than 3,300 associates with more than 300,000 systems installed globally.
LEON
leon-nanodrugs GmbH (LEON) is a technology provider specializing in equipment for the manufacturing of nanoparticle-based drug products, including RNA-based lipid nanoparticles (LNPs).
Our technology platform, featuring the modular FR-JET ® mixing reactor, enables a seamless transition from R&D to commercial-scale manufacturing, eliminating common challenges associated with tech transfer between scales.
Our portfolio of devices, NANOlab® for process development, NANOme® and NANOus® for GMP aseptic manufacturing, enable faster route to clinical batches and are suitable for both individualised scales and commercial production.
For individualized mRNA therapies, NANOme® is a groundbreaking piece of equipment designed to meet stringent regulatory requirements. Featuring fully GMP-compliant, closed, and automated aseptic processing with single-use sterile fluid paths, NANOme® ensures rapid, back-to-back manufacturing and contamination-free production of patient-specific batches. LEON’s technology platform empowers drug developers to optimize their manufacturing processes effortlessly, ensuring rapid progression from development to commercial manufacturing.
NanoImaging Services
NIS is a specialty CRO harnessing the power of cryo-TEM to help pharma and biotech companies discover and develop new therapeutics faster than ever before. NIS is the first and only GMP-compliant cryo-TEM lab in North America and is committed to providing rapid, flexible, cost-effective cryo-TEM.
A clear picture of nanoparticle formulations, like vaccine, gene, and drug delivery vehicles can mitigate the risk for unexpected complications. Cryo-TEM assesses drug encapsulation, morphology, lamellarity, impurities, & stability, and is a powerful, orthogonal technique.
Innovation Partners:
JenKem Technology
JenKem Technology offers large-scale GMP manufacturing of PEG lipids and innovative lipid products for mRNA and siRNA delivery, Cell Penetrating Peptide PEG products for siRNA delivery, and LNP formulation development services. DMFs were filed with US FDA and China CDE for several lipids and PEG products.
JenKem Technology also provides CDMO support for lipid products, research-grade LNP encapsulation for RNA, and analytical testing for LNP, RNA, and LNP-RNA formulations.
NanoFCM
NanoFCM is helping scientists deliver the next generation of nanomedicines by providing reliable quantitative measurements of the single nanoparticle size, concentration, and phenotyping. We are enabling new methods of nanoparticle analysis, providing invaluable data for process and product development from research stage through commercial release.
Exhibition Partners:
Ardena
Ardena is your premier integrated CDMO and leading nanomedicine partner, with a special focus on LNP (Lipid Nanoparticle) development. Our unparalleled service portfolio encompasses the entire LNP lifecycle, from early development to GMP manufacturing of payloads and LNPs. Additionally, we offer GMP aseptic fill-finish, clinical packaging, bioanalysis, and CMC regulatory support. Experience the seamless journey from concept to clinic with Ardena's comprehensive and expertly integrated LNP services.
Avanti Polar Lipids
Whatever your requirement, Croda Pharma’s extensive portfolio of Avanti lipids can meet your needs. We offer both research grade and GMP grade lipids to support discovery, clinical, and commercial LNP manufacturing requirements including an extensive portfolio of phospholipids, PEG lipids, cationic lipids, functionalized lipids, sterols, and more. In addition, we specialize in custom lipid manufacturing of proprietary compounds, lipid formulation development, and preparation of custom lipid blends to make your project a success.
Cayman Chemical
Partner with Cayman and utilize 42 years’ experience in synthesis, purification, and characterization of lipids. Cayman manufactures an expansive selection of high-purity lipids utilized in LNP and liposome development including commercial and custom phospholipids, cationic and, anionic lipids. Our client-focused services include custom synthesis, purification, characterization, and custom API manufacturing. We couple your vision with our expertise to match your payload with the world’s best lipids and lipid chemists.
Helix Biotech
Helix Biotech is a Customer and Quality focused CDMO specializing in LNPs, Liposomes, and Hybrid Nanoparticles. Browse our selection of innovative tools and reagent systems, or reach out to us for assistance with your pre-clinical or clinical stage development, manufacturing, and analytical project.
Spectradyne
Spectradyne’s ARC™️ nanoparticle analysis system combines two orthogonal methods in a single system, for LNP size, concentration, payload analysis and surface targeting information. The ARC system overcomes all the limitations found with other technologies such as fluorescence NTA and flow cytometry.
- Simultaneous particle size, concentration & fluorescence-based phenotyping/payload measurement
- Electrical & optical: Simultaneous orthogonal measurements
- Quantitative, traceable fluorescence units (ERF or MESF)
- Compatible with traditional dyes & staining protocols (no wash steps required)
- Microliter sample sizes
- Works in complex backgrounds (serum, plasma)
KNAUER
KNAUER are a berlin-based manufacturer of high-tech scientific instruments, whose strength lies in liquid engineering.
KNAUER manufactures systems for the production of lipid nanoparticle-based formulations, such as mRNA vaccines. Their NanoProducer units, which use KNAUER’s Impingement Jets Mixing (IJM) technology, are used worldwide in the high-volume production of mRNA COVID-19 vaccines.
Their latest LNP system, the NanoScaler, is designed specifically for the pre-scale up R&D of new mRNA therapies.
Think LNP. Think KNAUER.
XGen
At XGen Bio, we are dedicated to empowering innovation in lipid nanoparticle (LNP) technology. Our portfolio includes cutting-edge microfluidic devices and T-mixers designed to streamline LNP formulation and accelerate the development of groundbreaking therapeutics.
Beyond providing reliable and efficient tools, we collaborate with our clients to optimize their processes, offering expertise in LNP formulation and process development. Whether you're developing gene therapies, vaccines, or other LNP-based medicines, XGen Bio is your trusted partner in bringing ideas to life.
ONI
Founded in 2016, ONI is now a leading and rapidly growing life science company redefining the boundaries of scientific discovery with super-resolution microscopy. The Nanoimager, ONI’s flagship product, is the world’s first desktop super-resolution microscope, capable of visualizing, tracking and imaging individual molecules in living cells with 20 nm resolution. Each team at ONI – from scientists to software engineers to sales teams – wants to create and provide innovative technologies that will empower researchers and users alike. We want to accelerate human discovery and fight disease and in doing so drive super-resolution microscopy to novel frontiers.
Sinopeg
Xiamen Sinopeg Biotech Co., Ltd. is dedicated to drug delivery systems and related medical device business, focusing on the research, development, production and sales of high-end drug delivery carriers/auxiliary materials/APIs, medical materials, including but not limited to polyethylene glycol derivatives, lipid products, blood sugar control drug modifiers, block copolymers, ADC/ProTAC linkers, biodegradable polymers, exosomes, viral-like particles, as well as providing CDMO and solution services. These products are widely used in long-acting protein/peptide drugs, COVID-19 mRNA vaccines, small nucleic acid drugs, blood sugar control drugs, macromolecular micelle drugs, liposome drugs, gene therapy drugs, immunosuppressants, ADC drugs, ProTAC drugs, medical hydrogels, and other fields, placing the company in a leading position in the industry.
Phosphorex
Phosphorex is a leading provider of drug delivery technologies and solutions. By harnessing the potential of microspheres and nanoparticles for drug delivery, Phosphorex offers tailored solutions and enabling technologies to optimize a drug's release rate, targeting ability, bioavailability, and deliverability, with the goal of achieving desired therapeutic effects while reducing adverse clinical outcomes. Phosphorex supports pharmaceutical and biotech companies through all phases of their development, from proof of concept to clinical studies. Phosphorex's mission is to help our partners solve complex problems and develop successful drugs to help patients.
Northern RNA
Curapath
Curapath provides unmatched technical and analytical expertise in the custom design, development, and end-to-end GMP manufacture of polymer and lipid-based drug delivery systems to support cell therapy, gene therapy, and vaccine delivery. Our expertise in functional polymer and lipid excipients, formulation, and manufacturing of nanoparticles make Curapath the right partner to drive your therapeutic development. We deliver consultative, hands-on guidance from preclinical development through commercial-scale GMP manufacturing. Curapath is a knowledgeable partner you can trust to move fast, manufacture smart, and provide support through your drug development journey, accelerating your speed to the clinic. We help our partners solve even the most complex drug delivery challenges.
Event Partners:
Samyang BioPharm
Samyang Biopharm develops innovative gene delivery solutions using its proprietary SENS (Selectivity Enabling NanoShell) platform for diverse payloads. SENS is a polymer-lipid hybrid nanoparticle-based platform enabling tissue targeting, including spleen, lung, liver, brain, enhancing safety and efficacy. Samyang has facilities capable of producing GMP-grade polymers and lipids for early phase clinical trials. The company plans to expand its services, offering end-to-end solutions from early research to manufacturing at scale.
